Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

Savyon Chlamydia Genus Specific ELISA kits

Products are for professional/laboratory use only.

The SeroELISA™ Chlamydia kits are intended for the determination of IgG, IgM or IgA antibody to Chlamydia in human serum sample.

Details:

  • Based on purified L2 serovar MOMP antigen
  • Chlamydia genus-specific
  • Highly sensitive
  • Simple interpretation of results
  • Ready to use conjugate
  • Serum

Product Code

Product Description

Size

SVA11101D

Savyon SeroELISA Chlamydia IgG Kit

96 Tests

SVA11201D

Savyon SeroELISA Chlamydia IgM Kit

96 Tests

SVA11301D

Savyon SeroELISA Chlamydia IgA Kit

96 Tests


Features:

  • Superior clinical and analytical performance
  • Proprietary state of the art core biologicals – Antigens, antibodies and enzyme conjugates
  • Ready-to-use color-coded unified reagents
  • Automation compatibility with all common ELISA processors
  • Short and unified running protocols
  • Convenience – Based on break-apart 8 wells strip
  • format, equally suited for both high or low volume use
  • For quantitative or semi-quantitative assays – Built-in controls for standard curve

Contact us to request an insert sheet

Contact Us Now >



Request a Quote

Request Quote

Recent Posts

Fungal Infection – Assays and Controls*

IMMY | Vircell IMMY’s rapid fungal assays and Vircell’s external controls deliver reliable, room temperature diagnostics with built-in quality assurance for streamlined serology workflows. Vircell…

Read full article

Vircell – VirClia Extraction Tube

Discover Vircell’s VirClia Extraction Tube, an innovative pre-dispensed tube featuring a one-step filtering process that eliminates the need for centrifugation, thereby significantly simplifying the pre-analytical…

Read full article

Advancing Sepsis Diagnostics—Journal of Clinical Medicine (JCM), Honors SeptiCyte RAPID* Study

  Immunexpress are delighted to announce that the study, “Validation of SeptiCyte® RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation,” has been selected as an Editor’s Choice Paper for 2024 by the Journal of Clinical Medicine (JCM) MDPI Editorial Team. This honour…

Read full article